These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4353152)

  • 1. [Effect of highly purified D-thyroxine ("Dyno") in hyperlipoproteinemias type II a and II b].
    von Löwis of Menar P; Klemens UH
    Verh Dtsch Ges Inn Med; 1972; 78():1623-5. PubMed ID: 4353152
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of hyperlipoproteinemias type II a and II b using dextro-thyroxine or D,L-alpha-methyl-thyroxine-ethylester].
    Schwartzkopff W
    Verh Dtsch Ges Inn Med; 1972; 78():1621-3. PubMed ID: 4353151
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of primary lipoproteinemia type IIa and IIb with highly purified dextro-thyroxine (D-T4). Controlled study in ambulant conditions].
    Klemens UH; von Löwis P
    Dtsch Med Wochenschr; 1974 Mar; 99(11):487-93. PubMed ID: 4365703
    [No Abstract]   [Full Text] [Related]  

  • 4. The primary hyperlipoproteinemias.
    Bybee DE; Hamilton RD
    J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the effect of d-thyroxine in patients with increased serum lipid level].
    Steger H
    Wien Klin Wochenschr; 1968 Nov; 80(47):887-98. PubMed ID: 5717659
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of primary hyperlipoproteinemia type IIa and IIb with dextrothyroxine (author's transl)].
    Koschinsky T; Vogelberg KH; Gries FA
    Dtsch Med Wochenschr; 1974 Mar; 99(11):494-6. PubMed ID: 4365046
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative treatment of hyperlipoproteinaemias in chimpanzees.
    Vastesaeger M; Blaton V; Declercq B; Vercruysse J; Vandamme D; Peeters H; Mortelmans J
    Acta Zool Pathol Antverp; 1974; 58(0):79-96. PubMed ID: 4365833
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of sodium d-thyroxine on the hiperlipedemia, hypercholesteremia, triglycerides and serum lipoproteins in patients with arteriosclerosis].
    Mazzei ES; Mazzei CM; Gotelli C
    Prensa Med Argent; 1967 Mar; 54(5):199-203. PubMed ID: 5605172
    [No Abstract]   [Full Text] [Related]  

  • 9. [Decreasing effect of DL-alpha-methylthyroxine-ethylester, D-thyroxine (DT4), D-triiodothyronine (DT3) and a combination of DT4 + DT3 on serum lipids in primary hyperlipoproteinemia Type IIa and b].
    Koschinsky T; Gries FA; Vogelberg KH; Miss H; Jahnke K; Canzler H; Horster FA; Herrmann J; Wildmeister W; Krüskemper HL
    Verh Dtsch Ges Inn Med; 1974; 80():1262-4. PubMed ID: 4375893
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV].
    Romics L; Karádi I; Simonyi E
    Orv Hetil; 1980 Oct; 121(43):2629-31. PubMed ID: 7208011
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduction of serum cholesterol in type II hyperlipidaemia by guar gum.
    Jenkins DJ; Leeds AR; Slavin B; Mann J; Jepson EM
    Proc Nutr Soc; 1977 Dec; 36(3):94A. PubMed ID: 202966
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of hyperlipoproteinemias (author's transl)].
    Crepaldi G; Fellin R; Briani G; Baggio G; Baiocchi MR
    G Ital Cardiol; 1974; 4(3):332-40. PubMed ID: 4367439
    [No Abstract]   [Full Text] [Related]  

  • 13. D-Thyroxine in hyperbetalipoproteinaemia.
    Myburgh DP; Joubert CP
    S Afr Med J; 1975 Oct; 49(42):1757-8. PubMed ID: 171778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipoproteins and hyperlipoproteinemias].
    Weisweiler P; Schwandt P
    Fortschr Med; 1980 Mar; 98(9):313-6. PubMed ID: 7372258
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the combination of nicotinic acid and propranolol in very low doses on blood lipids in man.
    Avogaro P; Capri C; Cazzolato G; Pais M; Trabuio GF
    Atherosclerosis; 1974; 20(2):395-400. PubMed ID: 4369975
    [No Abstract]   [Full Text] [Related]  

  • 16. [Classification of hyperlipoproteinemias].
    Zabel R
    Dermatol Monatsschr; 1974 Feb; 160(2):134-50. PubMed ID: 4369507
    [No Abstract]   [Full Text] [Related]  

  • 17. The dyslipoproteinemias.
    Brown DF
    Acta Diabetol Lat; 1972 Dec; 9 Suppl 2():18-52. PubMed ID: 4369284
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin.
    Glueck CJ; Tsang RC; Fallat RW; Scheel D
    Pediatrics; 1974 Jul; 54(1):51-5. PubMed ID: 4365953
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical evaluation of cinnarizine in hyperlipaemic patients.
    Saba P; Galeone F; Salvadorini F; Guarguaglini M; Houben JL
    G Clin Med; 1974 Aug; 55(8):586-99. PubMed ID: 4377134
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis and treatment of Type II and Type IV hyperlipoproteinemia in the office practice setting.
    Millett F; Sielski J; Stoll H; Alston N; Gail S
    PA J; 1976; 6(2):54-9. PubMed ID: 10235781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.